Alfadyse Medi Care Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 30-12-2024
- Paid Up Capital ₹ 0.50 M
as on 30-12-2024
- Company Age 4 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 0.60 M
as on 30-12-2024
- Revenue 389.08%
(FY 2022)
- Profit 31.33%
(FY 2022)
- Ebitda 46.22%
(FY 2022)
- Net Worth 379.31%
(FY 2022)
- Total Assets 102.48%
(FY 2022)
About Alfadyse Medi Care
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹0.60 M.
Reshma Haidry and Syed Manzoor serve as directors at the Company.
- CIN/LLPIN
U51909BR2020PTC046346
- Company No.
046346
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jun 2020
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Patna
Industry
Company Details
- Location
Bhagalpur, Bihar, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Alfadyse Medi Care Private Limited offer?
Alfadyse Medi Care Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, Patient Monitoring System, OT Tables.
Who are the key members and board of directors at Alfadyse Medi Care?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Reshma Haidry  | Director | 15-Jun-2020 | Current |
| Syed Manzoor | Director | 15-Jun-2020 | Current |
Financial Performance of Alfadyse Medi Care.
Alfadyse Medi Care Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 389.08% increase. The company also saw a substantial improvement in profitability, with a 31.33% increase in profit. The company's net worth Soared by an impressive increase of 379.31%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Alfadyse Medi Care?
In 2022, Alfadyse Medi Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹0.60 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.06 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 10 Nov 2020 | State Bank Of India | ₹0.60 M | Open |
How Many Employees Work at Alfadyse Medi Care?
Alfadyse Medi Care has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Alfadyse Medi Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Alfadyse Medi Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.